Computer Predicts Anti-Cancer Molecules

Contact

Georgia Tech Media Relations
Laura Diamond
laura.diamond@comm.gatech.edu
404-894-6016
Jason Maderer
maderer@gatech.edu
404-660-2926

Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

CoMet predicts which cell components have effect on cancer

Full Summary:

A new computer-based method of analyzing cellular activity has correctly predicted the anti-tumour activity of several molecules. Research published today in BioMed Central's open access journal, Molecular Cancer, describes 'CoMet' - a tool that studies the integrated machinery of the cell and predicts those components that will have an effect on cancer.

Media
  • Tech Tower Tech Tower
    (image)

A new computer-based method of analyzing cellular activity has correctly predicted the anti-tumour activity of several molecules. Research published today in BioMed Central's open access journal, Molecular Cancer, describes 'CoMet' - a tool that studies the integrated machinery of the cell and predicts those components that will have an effect on cancer.

Jeffery Skolnick, professor in the School of Biology and director of the Center for the Study of Systems Biology, in collaboration with John McDonald, chair of the School of Biology, led a team from the Georgia Institute of Technology who have developed this new strategy.

"This opens up the possibility of novel therapeutics for cancer and develops our understanding of why such metabolites work. CoMet provides a deeper understanding of the molecular mechanisms of cancer," said Skolnick.

The small molecules that are naturally produced in cells are called metabolites. Enzymes, the biological catalysts that produce and consume these metabolites, are created according to a cell's genetic blueprints. Importantly, however, the metabolites can also affect the expression of genes.

"By comparing the gene expression levels of cancer cells relative to normal cells and converting that information into the enzymes that produce metabolites," said Skolnick, "CoMet predicts metabolites that have lower concentrations in cancer relative to normal cells."

The research proves that when such putatively depleted metabolites are added to cancer cells, they exhibit anticancer properties. In this case, growth of leukemia cells was slowed by all nine of the metabolites suggested by CoMet.

The future for this treatment looks bright, added McDonald. "While we have only performed cell proliferation assays, it is reasonable to speculate that some metabolites may also exhibit many other anticancer properties," he said. "These could be important steps on the road to a cure."

Related Links

Additional Information

Groups

News Room

Categories
Cancer Research, Life Sciences and Biology, Research
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
cancer cell, CoMet, mcdonald, molecule, skolnick
Status
  • Created By: David Terraso
  • Workflow Status: Published
  • Created On: Jun 16, 2008 - 8:00pm
  • Last Updated: Oct 7, 2016 - 11:01pm